Dengue-Zika: Correlates of Cross-Protection in Non-Human Primates
Dengue-Zika: Correlates of Cross-Protection in Non-Human Primates
批准号:
10534163
负责人:
CARLOS A SARIOL
金额:
$67.74万
依托单位国家:
美国
项目类别:
财政年份:
2020
资助国家:
美国
项目状态:
已结题
起止时间:
2020-01-09 至 2024-12-31
关键词:
AdultAmericasAnimal ModelAnimalsAntibody-Dependent EnhancementAntigen-Antibody ComplexAreaB-LymphocytesBehaviorBreedingCD4 Positive T LymphocytesCD8-Positive T-LymphocytesCD8B1 geneCaribbean regionCellsCellular ImmunityChildClinicalComplementCross-PrimingDataDengueDengue InfectionDengue VaccineDengue VirusDevelopmentDiagnosisDiagnostic ProcedureDisease OutbreaksEpidemicEpidemiologyExperimental DesignsExposure toFlavivirusGuillain Barré SyndromeHerd ImmunityHumanImmuneImmune SeraImmune responseImmune systemImmunityImmunocompetentImmunodeficient MouseImmunologic Deficiency SyndromesImmunologicsIn VitroInbreedingInfectionInflammatoryLinkMS4A1 geneMacacaMacaca mulattaMediatingModelingNewborn InfantOutcomePathogenesisPlayPopulationPregnancyPrimary InfectionPrimatesPublicationsResearchRoleSeriesSerologySystemT cell responseT-LymphocyteT-Lymphocyte EpitopesTestingTimeVaccine DesignViralViremiaVirusVirus DiseasesVirus ReplicationWorkZIKAZIKV diseaseZIKV infectionZika VirusZika virus vaccinecell typecongenital zika syndromecross immunitycross reactivitycytokinedesignexperimental groupexperimental studyimmunodeficient mouse modelimmunoregulationin vivomosquito-bornenonhuman primatepathogenpreventprotective effectresponsesecondary infectionsecondary outcomesevere denguetime intervaltooltransmission process
中文摘要
摘要
英文摘要
Abstract
Zika virus (ZIKV) is a re-emerging mosquito-borne Flavivirus that recently caused an outbreak in the Americas. The
establishment of ZIKV transmission cycle in tropical/sub-tropical regions that are endemic to other close-related flaviviruses
such as Dengue virus (DENV) has raised concerns, mainly by their cross-immunological interactions and the implications
of this for development of severe clinical manifestations. Several groups have demonstrated that DENV-immune serum
from humans can enhance ZIKV infection in vitro and in vivo in an immunodeficient mice model. This phenomenon known
as Antibody Dependent-Enhancement (ADE) has been linked to severe dengue clinical manifestations. Little is known about
the effect of a previous immunity to ZIKV on a subsequent DENV infection. It is highly necessary to characterize correlates
of protection in the control of a heterologous secondary DENV or ZIKV infection in the presence of previous DENV or
ZIKV immunity in an immunological competent animal model that resemble the human immune system like the Non-
Human Primates. Our group have preliminary data showing a potential protective role of the cellular immune response in
dengue- immune or ZIKV-immune subjects during a heterologous secondary infection with ZIKV or dengue. The overall
hypothesis behind this work is that the cross-primed cellular immune response may be critical controlling the DENV and
ZIKV infection and provides heterologous protection against each other. To test this hypothesis, we propose a series of
straightforward experiments by depleting the CD4+ or CD8+ or CD20+ cells at different time points before a primary or a
secondary infection with dengue or ZIKV. This type of experiment has not been performed before in NHP. For these
experiments we will use rhesus macaques bred and housed at the Caribbean Primate Research Center that has proven to be
the purer Indian-origin macaque population of all populations in the USA or imported animals, without having a significant
level of inbreeding. For first time in any study in the flavivirus field, we will use a large data on the MHC typing of this
population to characterize specific CD4 and/or CD8 T cells epitopes playing a role in the T cells immune response against
dengue and ZIKV. Understanding correlates of protection between ZIKV and DENV is essential to anticipate the outcome
of the secondary infection, the design of diagnostics methods and more relevant, to support the design of highly effective
ZIKV and DENV vaccines in the scenario of previous DENV or ZIKV immunity, respectively. Undoubtedly, NHP provide
us with a unique immunological tool very close to the human system to provide the answers to the questions we are outlying
on this application.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Dengue-Zika: Correlates of Cross-Protection in Non-Human Primates
-
批准号:10323002
-
项目类别:
-
资助金额:$68.5万
-
财政年份:2020
-
负责人:CARLOS A SARIOL
-
依托单位:
Dengue-Zika: Correlates of Cross-Protection in Non-Human Primates
-
批准号:10083183
-
项目类别:
-
资助金额:$69.54万
-
财政年份:2020
-
负责人:CARLOS A SARIOL
-
依托单位:
Viral Testing
-
批准号:10447031
-
项目类别:
-
资助金额:$82.18万
-
财政年份:2016
-
负责人:CARLOS A SARIOL
-
依托单位:
MHC Genetic Typing
-
批准号:10217280
-
项目类别:
-
资助金额:$28.06万
-
财政年份:2016
-
负责人:CARLOS A SARIOL
-
依托单位:
MHC Genetic Typing
-
批准号:10647890
-
项目类别:
-
资助金额:$28.3万
-
财政年份:2016
-
负责人:CARLOS A SARIOL
-
依托单位:
Viral Testing
-
批准号:10217279
-
项目类别:
-
资助金额:$85.68万
-
财政年份:2016
-
负责人:CARLOS A SARIOL
-
依托单位:
Viral Testing
-
批准号:10647888
-
项目类别:
-
资助金额:$82.18万
-
财政年份:2016
-
负责人:CARLOS A SARIOL
-
依托单位:
MHC Genetic Typing
-
批准号:10447032
-
项目类别:
-
资助金额:$28.18万
-
财政年份:2016
-
负责人:CARLOS A SARIOL
-
依托单位:
FACTORS ASSOCIATED WITH CHRONIC HEPATITIS C INFECTION
-
批准号:7381031
-
项目类别:
-
资助金额:$6.07万
-
财政年份:2006
-
负责人:CARLOS A SARIOL
-
依托单位:
ENHANCEMENT OF THE CPRC-SPF RHESUS MONKEY PROGRAM
-
批准号:8502561
-
项目类别:
-
资助金额:$236.79万
-
财政年份:2002
-
负责人:CARLOS A SARIOL
-
依托单位:
ENHANCEMENT OF THE CPRC-SPF RHESUS MONKEY PROGRAM
-
批准号:8693041
-
项目类别:
-
资助金额:$246.71万
-
财政年份:2002
-
负责人:CARLOS A SARIOL
-
依托单位:
ENHANCEMENT OF THE CPRC-SPF RHESUS MONKEY PROGRAM
-
批准号:8264420
-
项目类别:
-
资助金额:$254.4万
-
财政年份:2002
-
负责人:CARLOS A SARIOL
-
依托单位:
ENHANCEMENT OF THE CPRC-SPF RHESUS MONKEY PROGRAM
-
批准号:8896093
-
项目类别:
-
资助金额:$244.38万
-
财政年份:2002
-
负责人:CARLOS A SARIOL
-
依托单位:
Establishment & maintenance of a closed CPRC SPF colony
-
批准号:8304184
-
项目类别:
-
资助金额:$109.05万
-
财政年份:2000
-
负责人:CARLOS A SARIOL
-
依托单位:
Establishment & maintenance of a closed CPRC SPF colony
-
批准号:8854156
-
项目类别:
-
资助金额:$114.14万
-
财政年份:2000
-
负责人:CARLOS A SARIOL
-
依托单位:
Translational Science Initiative
-
批准号:10348650
-
项目类别:
-
资助金额:$20.61万
-
财政年份:1987
-
负责人:CARLOS A SARIOL
-
依托单位:
Translational Science Initiative
-
批准号:10532718
-
项目类别:
-
资助金额:$20.59万
-
财政年份:1987
-
负责人:CARLOS A SARIOL
-
依托单位:
Translational Science Initiative
-
批准号:10023453
-
项目类别:
-
资助金额:$74.97万
-
财政年份:1987
-
负责人:CARLOS A SARIOL
-
依托单位:
Viral Testing
-
批准号:9926680
-
项目类别:
-
资助金额:$85.68万
-
财政年份:--
-
负责人:CARLOS A SARIOL
-
依托单位:
MHC Genetic Typing
-
批准号:9926681
-
项目类别:
-
资助金额:$29.19万
-
财政年份:--
-
负责人:CARLOS A SARIOL
-
依托单位:
海外基金